ReviewTherapeutics and clinical risk management2023

Safety and Efficacy of Subcutaneous Daratumumab in Systemic AL Amyloidosis.

Michael Sang Hughes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.